Ortho Clinical Diagnostics Holdings plc Sustainability Profile
Ortho Clinical Diagnostics Holdings plc, commonly referred to as Ortho Clinical Diagnostics, is a leading player in the in vitro diagnostics industry, headquartered in Great Britain. Founded in 1939, the company has established itself as a pioneer in blood testing and transfusion diagnostics, serving healthcare providers across Europe, North America, and Asia. Specialising in innovative solutions for laboratory testing, Ortho Clinical Diagnostics offers a range of core products, including advanced blood screening systems and diagnostic reagents. Their commitment to quality and accuracy sets them apart in a competitive market. With a strong focus on enhancing patient care, the company has achieved significant milestones, including numerous regulatory approvals and partnerships that bolster its market position.
DitchCarbon Score
How does Ortho Clinical Diagnostics Holdings plc's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ortho Clinical Diagnostics Holdings plc's score of 25 is lower than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Ortho Clinical Diagnostics Holdings plc, headquartered in Great Britain, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of QuidelOrtho Corporation, which may influence its climate commitments and emissions reporting. As of now, there are no documented reduction targets or climate pledges from Ortho Clinical Diagnostics Holdings plc. The absence of specific emissions data and reduction initiatives suggests that the company may be in the early stages of developing its climate strategy or reporting framework. Given its relationship with QuidelOrtho Corporation, any potential emissions data or climate commitments may be inherited from this parent organization. However, specific details regarding emissions or targets from QuidelOrtho Corporation have not been provided in the available information. In summary, while Ortho Clinical Diagnostics Holdings plc is part of a larger corporate family, it currently lacks detailed emissions data and defined climate commitments. This context highlights the importance of monitoring future disclosures for any developments in their sustainability initiatives.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 26,212,000 | 00,000,000 |
| Scope 2 | 28,369,000 | 00,000,000 |
| Scope 3 | - | - |
How Carbon Intensive is Ortho Clinical Diagnostics Holdings plc's Industry?
How Carbon Intensive is Ortho Clinical Diagnostics Holdings plc's Location?
Ortho Clinical Diagnostics Holdings plc's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Ortho Clinical Diagnostics Holdings plc has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
